Multiple Myeloma Opportunities For Research And Education entered the industry of Medical Research in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Nancy J Kaufmann by calling (888) 486-4240 during business hours. You can also write to the business’ Single Location at , Columbus, Ohio OH 43220. You can also visit the company’s website at mmore.org. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Multiple Myeloma Opportunities For Research And Education |
| Representative: | Nancy J Kaufmann |
| Contact Number: | (888) 486-4240 |
| Website: | mmore.org |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 541720 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2008 |
| Income/Year: | $50.000 to $99.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Multiple Myeloma Opportunities For Research And Education is a company operating from Franklin, Ohio providing professional Medical Research and relevant B2B variables. It was founded in 2008 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.
With a current employee count of 1 to 4, Multiple Myeloma Opportunities For Research And Education has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Nancy J Kaufmann at (888) 486-4240 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address in Columbus, Ohio 43220 and can be engaged online through the company website at mmore.org, the company Twitter , and Facebook page .